by AIS refers to an obstruction of blood flow to the brain caused by a blood clot. Drugs or devices, such as thrombolytic therapy and mechanical thrombectomy are used for the treatment of AIS.
The global AIS market is estimated to be valued at US$ 10612.22 Bn in 2024 and is expected to exhibit a CAGR of 18.% over the forecast period 2024 To 2031.
AIS can potentially lead to long-term disabilities or death if not treated immediately. Rapid restoration of blood flow to the brain is the key to better clinical outcomes in patients with AIS. Thrombolytic drugs like tissue plasminogen activator (tPA) are the front-line treatment and help dissolve clots leading to reperfusion.However, its small therapeutic window of just 4.5 hours limits its reach. Mechanical thrombectomy devices help remove the clot directly through minimally invasive surgery and have a wider therapeutic window up to 24 hours. Growing efforts to spread awareness about time-critical care and rapidly evolving treatments are helping boost market growth.
Key Takeaways
Key players operating in the AIS market are F. Hoffmann-La Roche AG, Boehringer Ingelheim, Bayer AG, Pfizer Inc., Biogen, Daiichi Sankyo, Bristol-Myers Squibb, Johnson & Johnson, AstraZeneca, SanBio and Athersys Inc.
The key opportunities in the Acute Ischemic Stroke (Ais) Market include emergence of advanced devices and therapies with improved safety and efficacy. Increased clinical trials evaluating new therapeutic targets and angiogenesis inhibitors hold potential.
Globally, the rising economic burden of strokes, growing aging population, improving healthcare infrastructure and spending are fueling the market expansion especially in developing Asian and Latin American countries.
Market Drivers
The rising incidence of strokes owing to increasing risk factors like diabetes, hypertension, smoking is a major market driver. Strokes are among the top causes of mortality and disability worldwide. Improved awareness and accessibility to time-critical stroke care lead to early presentation and management of patients, driving the need for drugs and devices in AIS.
PEST Analysis
Political: The acute ischemic stroke market is regulated by various government agencies that approve and regulate drugs and medical devices used for treating AIS. Stringent regulations and approval procedures could affect the market growth.
Economic: Rising healthcare expenditures and growing demand for effective treatment options are driving the market. However, high treatment costs could hamper widespread adoption, especially in price-sensitive developing regions.
Social: Growing awareness about signs and symptoms of stroke and availability of innovative treatment options are increasing the social acceptability of seeking prompt medical help. This is supporting early diagnosis and intervention.
Technological: Advancements in areas such as thrombolytic therapy, endovascular surgery, and neurointerventional devices have significantly improved treatment outcomes in AIS. Further innovations to expand the treatment window are expected.
The regions where the acute ischemic stroke market in terms of value is concentrated currently include North America, Western Europe, and Japan. This can be attributed to advanced healthcare infrastructure, widespread health insurance, higher acceptance of high-cost therapies, and presence of major market players in these regions.
The Asia Pacific region, especially China and India, is poised to be the fastest growing regional market over the forecast period. Factors such as the rising geriatric population, growing incidence of stroke, increasing healthcare spending, and improving access to quality care are expected to support the market growth in Asia Pacific.
*Note:
1.Source: Coherent Market Insights, Public sources, Desk research
2.We have leveraged AI tools to mine information and compile it
About Author - Ravina Pandya
Ravina Pandya,a content writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemicals and materials, etc. With an MBA in E-commerce, she has expertise in SEO-optimized content that resonates with industry professionals. LinkedIn Profile
